1. 10x Genomics will report Q2 financial results on August 7, 2025. 2. A public conference call will discuss results and business outlook. 3. The company's products support major breakthroughs in biotechnology. 4. The webcast will be archived for 45 days post-event.
The upcoming earnings report may indicate positive growth trends, similar to past results. Strong performance could attract investor interest and drive stock price upward.
Earnings reports are critical for stock valuations; this one may confirm strong performance. Previous earnings have shown that good results positively influence TXG’s stock price.
The scheduled financial results are imminent and likely to influence short-term trading. Similar events typically see immediate market reactions based on projected growth and guidance.
PLEASANTON, Calif., July 10, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the second quarter ended June 30, 2025 after market close on Thursday, August 7, 2025. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company's website prior to the conference call.
Live audio of the webcast will be available on the "Investors" section of the company website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience, and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X (Twitter), Facebook, Bluesky or YouTube.
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
SOURCE 10x Genomics, Inc.